HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Read MorePosted by CLP Edit Staff | Jan 7, 2026 | Cervical (HPV) |
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Read MorePosted by CLP Edit Staff | Jan 6, 2026 | Infectious Diseases |
The new PCR test detects and quantifies hepatitis delta virus (HDV)-specific RNA in human EDTA plasma and serum.
Read MorePosted by CLP Edit Staff | Dec 29, 2025 | Compliance |
The compliance milestone adds to the company’s existing ISO certifications as enterprise deployments accelerate across pharmaceutical and diagnostic laboratory customers.
Read MorePosted by CLP Edit Staff | Dec 29, 2025 | Molecular Diagnostic Analyzers |
Partnership with Certest Biotec adds respiratory and STI molecular diagnostic panels for European laboratories.
Read MorePosted by Alyx Arnett | Dec 24, 2025 | Cervical (HPV) |
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
Read More